Micro–RNA-126 Reduces the Blood Thrombogenicity in Diabetes Mellitus via Targeting of Tissue FactorMarco Witkowski, Ursula Rauch-Kroehnert, Diethelm Tschoepe et al.|Arteriosclerosis Thrombosis and Vascular Biology|2016Cited by 80
Protease-activated receptor 2 deficiency mediates cardiac fibrosis and diastolic dysfunctionJulian Friebel, Ursula Rauch, Marco Witkowski et al.|European Heart Journal|2019Cited by 60
Vascular miR-181b controls tissue factor-dependent thrombogenicity and inflammation in type 2 diabetesMarco Witkowski, Ursula Rauch, Andrea Dörner et al.|Cardiovascular Diabetology|2020Cited by 52
MicroRNA-19a contributes to the epigenetic regulation of tissue factor in diabetesMarco Witkowski, Ursula Rauch, Carsten Skurk et al.|Cardiovascular Diabetology|2018Cited by 30
Metformin Is Associated with Reduced Tissue Factor Procoagulant Activity in Patients with Poorly Controlled DiabetesMarco Witkowski, Ursula Rauch, Andrea Dörner et al.|Cardiovascular Drugs and Therapy|2020Cited by 23